Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.
Research Interests

Papers共 15 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Abstract 3135: BSI-730, a bispecific antibody targeting HER2 and PD-L1 for the development of a first-in-class bispecific ADC
Xiaoyao Hao, Hongyan Li, Xiaodong F. Liu, Jinyu Liu, Wenwen Dai, Ying Pan, Hui-Han Hu, Jun Li,Shukai Xia, Qun Lyu,Hugh M. Davis,Mingjiu Chen,
Cancer Researchno. 6_Supplement (2024): 3135-3135
Cited0Views0Bibtex
0
0
Abstract 5298: BSI-093, a best-in-class anti-BTN3A monoclonal antibody for cancer immunotherapy by activation of Vg9Vd2 T cells
Wenwen Dai, Jun Li, Jinyu Liu, Hongyan Li, Xiaodong F. Liu,Shukai Xia, Qun Lyu,Hugh M. Davis,Mingjiu Chen,Zeyu Peng
Cancer Researchno. 6_Supplement (2024): 5298-5298
Cited0Views0Bibtex
0
0
Abstract 1343: BSI-111, a highly selective anti-CD16a monoclonal antibody with potent agonist activity for building a NK cell engager platform
Jinyu Liu, Wenwen Dai, Hongyan Li, Xiaodong F. Liu, Jun Li,Shukai Xia, Qun Lyu,Hugh M. Davis,Mingjiu Chen,Zeyu Peng
Cancer Researchno. 6_Supplement (2024): 1343-1343
Cited0Views0Bibtex
0
0
Abstract 6367: BSI-507, a first-in-class bispecific antibody targeting PD1 and PVRIG for cancer immunotherapy
Zeyu Peng, Xiaodong F. Liu, Hongyan Li, Wenwen Dai, Jinyu Liu, Xiaoyao Hao,Shukai Xia, Qun Lv,Hugh M. Davis,Mingjiu Chen, Z. Mark
Cancer Researchno. 7_Supplement (2023): 6367-6367
Cited0Views0Bibtex
0
0
BSI-508, a novel bispecific fusion molecule targeting PD1 and CD47 for cancer immunotherapy
Zeyu Peng, Xiaodong F. Liu, Hongyan Li, Wenwen Dai, Jinyu Liu, Xiaoyao Hao,Shukai Xia, Qun Lv,Hugh M. Davis,Mingjiu Chen, Mark Z. Ma
CANCER RESEARCHno. 7 (2023)
Cited0Views0Bibtex
0
0
1176 BSI-510, a novel bispecific molecule combining an anti-Siglec-15 antibody with cytokine GM-CSF for enhanced antitumor efficacy
Hongyan Li, Zemeng Ma, Xiaoyao Hao, Xiaodong F Liu, Wenwen Dai,Yuxiang Liu,Jinyu Liu,Shukai Xia, Mark Z Ma,Mingjiu Chen,Zeyu Peng
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
Cited0Views0Bibtex
0
0
Abstract 2958: BSI-508, a novel bispecific fusion molecule targeting PD1 and CD47 for cancer immunotherapy
Zeyu Peng, Xiaodong F. Liu, Hongyan Li, Wenwen Dai, Jinyu Liu, Xiaoyao Hao,Shukai Xia, Qun Lv,Hugh M. Davis,Mingjiu Chen, Z. Mark
Cancer Researchno. 7_Supplement (2023): 2958-2958
Cited0Views0Bibtex
0
0
Load More
Author Statistics
  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn